Comments
Loading...
PepGen (NASDAQ:PEPG) Stock Quotes, Forecast and News Summary
PepGen Stock (NASDAQ: PEPG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy PepGen (PEPG) stock?
You can purchase shares of PepGen (NASDAQ:PEPG) through any online brokerage.
Who are PepGen (PEPG) competitors?
Other companies in PepGen’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO) and Adaptimmune Therapeutics (NASDAQ:ADAP).
What is the forecast, or price target, for PepGen (PEPG) stock?
PepGen has a consensus price target of $22.20.
What is the current price for PepGen (PEPG)?
The stock price for PepGen (NASDAQ: PEPG) is $4.2 last updated November 15, 2024 at 11:59 AM EST.
Does PepGen (PEPG) pay a dividend?
There are no upcoming dividends for PepGen.
When is PepGen (NASDAQ:PEPG) reporting earnings?
PepGen’s Q3 earnings are confirmed for Thursday, November 7, 2024.
Is PepGen (PEPG) going to split?
There is no upcoming split for PepGen.
What sector and industry does PepGen (PEPG) operate in?
PepGen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.